MODIFIED SMALL INTERFERING RNA MOLECULE AND METHOD OF USE

PROBLEM TO BE SOLVED: To provide a method for inactivating a hepatitis virus by inhibiting the viral replication in an infected cell using 2'-fluorine dsRNA or siRNA, relating to the field of nucleic acid detection and to the phenomenon of RNA silencing, or RNA interference (RNAi).SOLUTION: The...

Full description

Saved in:
Bibliographic Details
Main Authors HOUGHTON MICHAEL, HUANG CHIYUAN
Format Patent
LanguageEnglish
Published 07.06.2012
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
SUGARS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a method for inactivating a hepatitis virus by inhibiting the viral replication in an infected cell using 2'-fluorine dsRNA or siRNA, relating to the field of nucleic acid detection and to the phenomenon of RNA silencing, or RNA interference (RNAi).SOLUTION: The method for inactivating the virus that causes hepatitis in a patient includes (a) s step of administering to the patient a modified double-stranded RNA (dsRNA) or modified short-chain interfering RNA (siRNA) in an effective amount to inactivate the virus and (b) a step of administering to the patient a cholesterol-lowering drug.
Bibliography:Application Number: JP20120054494